Giant Fungated Locally Advanced Breast Carcinoma Responded to Hypofractionated Radiotherapy Combined with Apatinib: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Giant Fungated Locally Advanced Breast Carcinoma Responded to Hypofractionated Radiotherapy Combined with Apatinib: A Case Report and Literature Review

Published:2021-01 Issue: Volume:Volume 13 Page:605-611
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Liu Hui,Liu Bailong,Ma Yunfei,Guo Liang,Wu Di,Shi Aiping^ORCID,Liu Min

Publisher

Informa UK Limited

Subject

Oncology

Reference29 articles.

1. Recent advances in nanotheranostics for triple negative breast cancer treatment

2. Breast-Conserving Therapy for Triple-Negative Breast Cancer

3. Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer

4. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

5. Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial;npj Breast Cancer;2022-09-20

2. Effect of X-ray radiation on the pharmacokinetics of apatinib in vivo in rats;Frontiers in Pharmacology;2022-09-12

3. The efficacy and safety of low-dose Apatinib in the management of stage IV luminal-type breast cancer: a case report and literature review;Anti-Cancer Drugs;2021-06-18

4. Antineoplastics;Reactions Weekly;2021-04